Clinical trial
Safety and Efficacy of KALOMIN™ Tab. in Patients With Acute Bronchitis
NCT02151734 is registered in ClinicalTrials.gov with Korea United Pharm. Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of KALOMIN™ Tab. in Patients With Acute Bronchitis
- Lead sponsor
- Korea United Pharm. Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2013
- Completion date
- Not reported
- Enrollment
- 242 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute bronchitis